Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

Parabolic Drugs Ltd.

BSE: 533211 | NSE: PARABDRUGS | ISIN: INE618H01016 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Oct 18, 16:00
1.02 -0.05 (-4.67%)
Volume
AVERAGE VOLUME
5-Day
23,814
10-Day
12,617
30-Day
5,027
50,000
  • Prev. Close

    1.07

  • Open Price

    1.02

1.02

Today’s L/H

1.02
0.59

52 Wk L/H

3.23
1.02

L/U Price Band

1.12
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP
    1.02
  • Market Depth (18 Oct 2019)

    BUYSELL
    QTY PRICE PRICE QTY
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 0.00 0.00 0
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Oct 22, 15:32
1.00 0.00 (0.00%)
Volume
AVERAGE VOLUME
5-Day
11,900
10-Day
18,972
30-Day
12,030
0
  • Prev. Close

    1.00

  • Open Price

    0.00

0.00

Today’s L/H

0.00
0.45

52 Wk L/H

3.15
0.95

L/U Price Band

1.05
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  • VWAP
    0.00
    Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.
    Series: BE
  • DELIVERY AVERAGES
    3-Day
    70.33%
    5-Day
    86.46%
    8-Day
    86.96%
    Deliverables
  • SMA VOLUME
    30
    50
    150
    200
    SMA

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      6.31
    • P/E
      -
    • Book Value (Rs)
      -143.31
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      27.79
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      70.33
      5-Day
      86.46
      8-Day
      86.96
      73.44

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      6.31
    • P/E
      -
    • Book Value (Rs)
      -142.40
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      27.79
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      70.33
      5-Day
      86.46
      8-Day
      86.96
      73.44

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
30 - -
50 - -
150 - -
200 - -
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD

Action in Parabolic Drugs Ltd.

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Oct 18, 10:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Oct 17, 10:35

  • Only Buyers

    Only Buyers in Parabolic Drugs on BSE

    Oct 15, 11:05

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Oct 15, 10:05

  • Only Buyers

    Only Buyers in Parabolic Drugs on BSE

    Oct 11, 15:10

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Oct 10, 13:55

  • Only Buyers

    Only Buyers in Parabolic Drugs on BSE

    Oct 07, 15:00

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Oct 07, 11:30

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Oct 04, 11:15

  • Only Sellers

    Only Sellers in Parabolic Drugs on NSE

    Oct 01, 10:55

  • Only Buyers

    Only Buyers in Parabolic Drugs on BSE

    Sep 30, 13:45

  • Technicals

    Parabolic Drugs closes above 150-Day Moving Average of 1.14 today.

    Sep 27

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Sep 27, 14:45

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Sep 26, 10:30

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Sep 25, 11:15

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Sep 24, 11:15

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Sep 23, 10:20

  • Only Buyers

    Only Buyers in Parabolic Drugs on BSE

    Sep 20, 12:40

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Sep 19, 13:45

  • Only Buyers

    Only Buyers in Parabolic Drugs on NSE

    Sep 18, 10:05

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Jun 2019 Mar 2019 Dec 2018 Sep 2018 Jun 2018
Net Sales -- -- 0.22 4.92 12.85
Other Income 0.01 0.01 0.01 0.66 0.13
PBDIT -1.95 -1.97 -2.01 -5.92 -4.86
Net Profit -7.49 -8.70 -7.09 -14.35 -10.52

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 61.89 61.89
Networth -886.99 -846.33
Total Debt 984.70 984.11
Net Block 304.40 326.37
Investments 6.34 6.34
Total Assets 97.71 137.78

Historical Prices

On
Current Price %Gain / Loss
Open Price 2.54 1.02
-59.84
High Price 2.79 1.02
-63.44
Low Price 2.54 1.02
-59.84
Close Price 2.79 1.07
-61.65
Volume 1,700 50,000
2841.18
On
Current Price %Gain / Loss
Open Price 2.55 0.00
-100
High Price 2.65 0.00
-100
Low Price 2.55 0.00
-100
Close Price 2.65 1.00
-62.26
Volume 1,325 0
-100
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11588.40 -73.50 -0.63
SENSEX 38963.84 -334.54 -0.85
NIFTY BANK 29411.15 290.90 1.00
NIFTY IT 14688.65 -721.45 -4.68
S&P BSE Smallcap 13190.37 63.54 0.48
Index Price Change %Chg
Nasdaq (Oct 23) 8,122.15 -40.84 -0.50
FTSE (Oct 22) 7,212.49 48.85 0.68
CAC (Oct 22) 5,657.69 9.34 0.17
DAX (Oct 22) 12,754.69 6.73 0.05
SGX Nifty (Oct 23) 11,634.50 16.50 0.14

CORPORATE ACTION

Date Agenda
May 29, 2019 Audited Results
Nov 14, 2018 Quarterly Results
Type Dividend% Ex-Dividend date
Final 2.50 Sep 24, 2012
Final 5.00 Sep 19, 2011
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Parabolic Drugs
Old FV New FV Ex-Split
No Splits Information is available for Parabolic Drugs
Ratio Premium Ex-Bonus
No Rights Information is available for Parabolic Drugs
Date Agenda
- -
Sep 29, 2017 -
Sep 29, 2016 -
Sep 29, 2015 -
Sep 30, 2014 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 December 2018 September 2018 March 2018
Promoters 37.79 37.79 37.79 37.79
Pledged 96.71 96.71 96.71 96.71
FII/FPI 8.06 8.06 8.06 8.06
Total DII 12.19 12.54 12.62 13.7
Fin.Insts 0.57 0.57 0.57 0.57
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 11.62 11.97 12.05 13.13
Others 41.95 41.6 41.52 40.44
Total 99.99 99.99 99.99 99.99

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Parabolic Drugs 1.02 0.00 3.23 0.59 6.31 18.08 -40.66
Sun Pharma 405.55 1.03 616.50 350.40 97305.03 10,303.21 816.60
Dr Reddys Labs 2812.35 3.25 2965.20 2065.30 46726 10,625.50 1,277.30
Divis Labs 1742.55 0.22 1768.80 1214.25 46259.23 4,879.66 1,332.65
Ranbaxy Labs 859.80 0.00 869.70 371.50 36598.55 6,864.94 -879.00

COMPANY OVERVIEW

Parabolic Drugs Limited (PDL), founded in 1996, is engaged in the manufacture including contract manufacture of APIs and API intermediates. In the year 2011, the company has stepped up in the value chain by foraying into the domestic formulations. Today PDL has four large scale facilities, three state of the art manufacturing plants at Derabassi, Chachhrauli and Panchkula for over 50 API and API intermediates across antibiotics and non antibiotic therapies and a Custom Synthesis and R&D centre at Barwala, Haryana. The company is surging ahead with the right set of drivers backward and forward integration, world class infrastructure, R&D strengths, diversified product basket across different therapeutic segments and Intellectual Property Rights in the form of DMFs, and Patents for novel processes.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Pranav Gupta

      Managing Director

    • Vineet Gupta

      Whole Time Director

    • Sanjeev Kumar

      Director

    • Jagjit Singh Chahal

      Director

    • Vandana Singla

      Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Parabolic Drugs Ltd.

Parabolic Drugs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 533211 and the NSE with an NSE Code of PARABDRUGS.

Related Searches